Speaker(s): 

Patrick J. Callaghan, MD, Staff Member, Geisinger - has nothing to disclose.
Mentor: Dr. Cosmin Sandulescu 

Moderator(s): 

Learning Objectives: 

1. Define a “one-arm crossover design” and discuss the benefits of such design ​
2. State which clinical features of normal pressure hydrocephalus can be improved with shunting and by how much​
3. Describe complications that can be related to CSF diversion with shunting ​

At the conclusion of this session, the participant should be able to: 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Emily Sun, DO and Cortney Houtz, LPN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.

Questions: 
 

1. What are advantages of the one-arm crossover study design? ​
2. How does this trial inform your discussion with patient’s about managing NPH symptoms? ​
3. What is an acceptable risk:benefit? (philosophical) ​